IP Library Granted Patent US 10,161,000
Granted Patent B2
US 10,161,000 · App. 15/133,768 · Granted Dec 25, 2018

Hydroxymethyl linkers for labeling nucleotides

Inventor: Jerzy Olejnik (Brookline, MA)
Assignee: QIAGEN WALTHAM, INC.
C12Q1/6869C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,161,000
App. No.
15/133,768
Granted
Dec 25, 2018
Kind
B2
Abstract

The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.

Claims (7)

1. A method of incorporating labeled nucleotide analogues into nucleic acid, comprising:

a) providing a plurality of nucleic acid template molecules, a polymerase, and a plurality of types of nucleotide analogues wherein each type of nucleotide analogue is labeled with a unique label and contains a removable chemical moiety capping the 3′-OH group (PG), wherein the label (M) is attached to the base through a chemically cleavable linker (CL) to hydroxymethyl group according to the following structures:

b) incorporating a first nucleotide analogue with said polymerase; and

c) detecting the label of the incorporated nucleotide analogue.

2. The method of claim 1 , wherein said label is selected from the group consisting of 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene, Rhodamine, Carboxyrhodamine and Cyanine.

3. The method of claim 1 , wherein said removable chemical moiety capping the 3′-OH group comprises an azido group.

4. The method of claim 1 , wherein said removable chemical moiety capping the 3′-OH group comprises a disulfide bond.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2017
From: OLEJNIK, JERZY
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 041166/0846 →
Continuity (4)
Continuation 13950560 · Jul 25, 2013
Continuation 12764419 · Apr 21, 2010
Provisional Application 61171975 · Apr 23, 2009
Related Publication 20160326579A1 · Nov 10, 2016